SEAVI Advent is a private equity and venture capital firm established in 1984 and headquartered in Singapore, with additional offices in Hong Kong and Shanghai. As the first venture capital firm in Southeast Asia, it focuses on growth capital investments across various stages, including early-stage, mid-stage, and later-stage companies. SEAVI Advent primarily targets sectors such as business services, healthcare, consumer-related businesses, industrial technology, and environmental engineering. The firm seeks investment opportunities in the Asia Pacific region, particularly in Singapore, Malaysia, Hong Kong, Indonesia, and Mainland China. Typically, SEAVI Advent invests between $5 million and $25 million in companies with enterprise values ranging from $25 million to $100 million. The firm also prefers to take an active role in its portfolio companies by securing seats on their boards of directors.
1 Coleman Street #07-02A The Adelphi, Singapore 179803
Kevin Chan
Senior Partner
Hoe Boon Kwee
CFO and Partner
Derrick Lee
CEO and Managing Partner
Daniel Poh
Partner
Teo Yi-Dar
Senior Partner and Member of Investment Committee
Henry Yao Wei Min
Partner
1 past transactions
Sinocom Pharmaceutical
Series A in 2009
Sinocom Pharmaceutical, Inc., a pharmaceutical company, grows and sells natural herbs in the People's Republic of China. The company also sells various third party traditional Chinese medicine formulated products and western medicines. Its pharmaceutical products include over-the-counter and prescription pharmaceuticals. The company sells its products to hospitals, medical clinics, drug stores, and distributors. Sinocom Pharmaceutical, Inc. was founded in 1997 and is based in Central, Hong Kong.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.